Hughey, Andrew B. http://orcid.org/0000-0001-7099-5478
Gu, Xiaokui
Haymart, Brian
Kline-Rogers, Eva
Almany, Steve
Kozlowski, Jay
Besley, Dennis
Krol, Gregory D.
Ahsan, Syed
Kaatz, Scott
Froehlich, James B.
Barnes, Geoffrey D.
Funding for this research was provided by:
Blue Cross-Blue Shield of Michigan/Blue Care Network
National Institutes of Health (T32-HL007853)
Article History
First Online: 14 June 2018
Compliance with Ethical Standards
:
: Steve Almany: Grant support from Boston Scientific Watchman, Michigan Anticoagulation Quality, and Abbott Absorb trial. Consultant for Kona, Trice Orthopedics, and Micardia. Ownership/partnership/principal with Biostar Ventures and Ablative Solutions. Scott Kaatz: Grant support from Boehringer-Ingelheim, Bristol-Myers Squibb, Bayer/Jansen/Johnson and Johnson, Eisai, Iverson Genetics Diagnostics/Medicare, National Institute of Health, Canadian Institute of Health Research, Blue Cross/Blue Shield of Michigan. Speaker honorarium from Jansen/Johnson and Johnson, Boehringer-Ingelheim, and Bristol-Myers Squibb. Consultant for Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Jansen/Johnson and Johnson, and Daiichi Sankyo. Non-profit board membership with AC Forum, National Certification Board of Anticoagulation Providers, and National Blood Clot Alliance Medical and Scientific Advisory Board. James B. Froehlich: Consultant for Merck, Bristol-Meyers Squibb, Pfizer, Sanofi-Aventis, Janssen Pharamaceuticals, Aralez and Ortho-McNeil. Research grants from Sanofi-Aventis, Blue Cross/Blue Shield of Michigan, Mardigian Foundation, Fibromuscular Disease Society of America. Geoffrey D. Barnes: Research grant support from Bristol Meyers Squibb/Pfizer and Blue Cross/Blue Shield of Michigan. Consultant for Portola and Aralez. Andrew B. Hughey, Xiaokui Gu, Brian Haymart, Eva Kline-Rogers, Jay Kozlowski, Dennis Besley, Gregory D. Krol, Syed Ahsan, declares that they have no conflict of interest.